Sudip Mukherjee

Title: Sudip Mukherjee: Innovator in Cancer Theranostics

Introduction

Sudip Mukherjee is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of nanomedicine, particularly in cancer theranostics. With a total of 3 patents to his name, Mukherjee is recognized for his innovative approaches to drug delivery systems.

Latest Patents

Mukherjee's latest patents include the development of bimetallic fluorescent nanocomposites for cancer theranostics. These fluorescent bimetallic nanocomposites, specifically silver-gold (Ag@Au-NC) and silver-platinum (Ag@Pt-NC), are prepared by reducing silver nitrate on gold and platinum nanoparticles using sodium borohydride. The biocompatible nanocomposites have shown promising multifunctional applications in cell imaging, bio-sensing, and therapeutics, as observed in both in vitro and in vivo experiments. Another notable invention is a gold nanoparticle-based formulation for cancer therapy, which utilizes bi-functional recombinant fusion proteins for targeted drug delivery to HER2+ cancers. This innovative approach combines gold nanoparticles with doxorubicin and siRNA, demonstrating stability and homogeneity in physicochemical studies.

Career Highlights

Sudip Mukherjee is affiliated with the Council of Scientific and Industrial Research, where he continues to advance research in nanomedicine. His work has garnered attention for its potential impact on cancer treatment and diagnostics.

Collaborations

Mukherjee collaborates with notable colleagues, including Chitta Ranjan Patra and Rajesh Kotcherlakota, to further enhance the scope and application of his research.

Conclusion

Sudip Mukherjee's innovative contributions to cancer theranostics through his patents highlight his role as a leading inventor in the field of nanomedicine. His work promises to pave the way for new therapeutic strategies in cancer treatment.